2010 Issues   /   Research

Recent Cardiology Studies November 2010

By U.S. Medicine

Clevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial Bed (CARVE)

Purpose: The CARVE study assesses the effect of Clevidipine, an ultra-short acting vasoselective calcium antagonist, on pulmonary vascular resistance and its utility for pulmonary vasoreactivity testing during right heart catheterization of patients with pulmonary hypertension.

Sponsor: North Texas Veterans Healthcare System

ClinicalTrials.gov Identifier: NCT01121458

Aerobic Exercise in Patients with Pulmonary Hypertension

Purpose: To determine if a rehabilitation exercise program can help people with pulmonary hypertension (PH) increase their physical activity. Patients with PH have an increase in blood pressure in the pulmonary blood vessels (artery, vein, or capillaries) that leads to shortness of breath, dizziness, fainting, and other symptoms.

Sponsor: National Institutes of Health Clinical Center (CC)

ClinicalTrials.gov Identifier: NCT00678821

Fat Gain and Cardiovascular Disease Mechanisms

Purpose: This series of novel studies directed at establishing the effects of increased body fat in otherwise healthy individuals will determine the distribution patterns of increased body fat and how both increased body fat and fat distribution relate to changes in blood pressure, and in neural, endothelial, and inflammatory mechanisms which have been implicated in the development and progression of cardiac and vascular disease. We will study non-obese subjects with and without a family history of hypertension.

Sponsor: Mayo Clinic

Collaborator: National Institutes of Health (NIH)

ClinicalTrials.gov Identifier: NCT00589498

Circulating Adenosine Levels Before and After IV Persantine®

Purpose: Persantine is a drug that is routinely used to determine blood flow to the heart in the diagnosis of coronary heart disease. Persantine causes an increase in the adenosine level in the blood. Adenosine is a naturally occurring substance in the body that can increase blood flow. Adenosine is normally removed from the bloodstream by an adenosine transporter, which is a protein that takes up adenosine from the blood into cells. The increase in adenosine levels in the blood is variable, and the cause for this variability is unknown. A mutation for this transporter gene may contribute to this variability, and may alter its function. The purpose of this study is to determine the relationship between the mutation and the transporter function.

Sponsor: University of Connecticut Health Center

Collaborator: US Army Research, DoD

ClinicalTrials.gov Identifier: NCT00760708

back to November articles


Related Articles

First-Ever Study Focuses on How Well VHA Cares for TIA Patients

INDIANAPOLIS — While many healthcare systems measure the quality of their stroke care, looking at performance early in the vascular disease process can help avoid acute events altogether.

Link Between Pain, Brain Disruption in Gulf War Veterans

MADISON, WI — Chronic musculoskeletal pain (CMP) affects about one-fourth of the 700,000 veterans deployed during the Persian Gulf War in 1990-1991. A study in the journal Pain pointed out that the cause of their... View Article


U.S. Medicine Recommends


More From news

News

Engineer Seeks to Make VAMCs More Energy Efficient Without Interrupting Their Mission

WASHINGTON—Anyone who’s ever worked in a hospital knows how much energy a facility of that size consumes. From the electricity to keep the lights on and the technology running to the water used to keep everything sterile, medical facilities can be far from energy efficient.

News

GAO: Applications for VHA Healthcare Benefits Frequently Mishandled

VHA does not have the right protocols in place to ensure applications for enrollment are processed in a timely manner or that enrollment determinations are accurate, according to a new report.

News

VA End-of-Life Care Push Increases Hospice Use Among Veterans

An intense effort by the VA to improve end-of-life care is paying off, with hospice use increasing more among veterans than nonveterans.

News

Paliperidone Palmitate Helps Some Schizophrenia Patients

Even though nearly half of all patients diagnosed with schizophrenia have a history of substance abuse (SA), data on treatment of schizophrenia with paliperidone palmitate (PP) among patients with comorbid SA have been limited.

News

How Do VA PCPs Respond to Insomnia Complaints?

Veterans have even higher rates of insomnia than other adults in the United States, and many seek treatment from their primary care physicians.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up